Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dornase alfa after grommet insertion for recurrent acute otitis media and glue ear
ACTRN12619001306101Phase 2Recruiting
- Sponsor
- Kids Research Institute Australia
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of dornase alfa, sponsored by Kids Research Institute Australia. Started Aug 2020; status: recruiting.
02
Drugs
dornase alfa
Beyond the preview
Go deeper on ACTRN12619001306101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001306101.